title: Glycosaminoglycan degradation fragments in mucopolysaccharidosis I.
abstract: The catabolism of glycosaminoglycans begins with endohydrolysis of polysaccharides to oligosaccharides followed by the sequential action of an array of exoenzymes to reduce these oligosaccharides to monosaccharides and inorganic sulfate. In a lysosomal storage disorder known as mucopolysaccharidosis I, caused by a deficiency of the exohydrolase alpha-l-iduronidase, fragments of two different glycosaminoglycans, dermatan sulfate and heparan sulfate, have been shown to accumulate. Oligosaccharides isolated from the urine of a mucopolysaccharidosis I patient using anion exchange and gel filtration chromatography were identified as di-, tri-, tetra-, penta-, and hexasaccharides using electrospray ionization-tandem mass spectrometry and shown to have nonreducing terminal alpha-l-iduronate residues, susceptible to digestion with alpha-l-iduronidase. The presence of odd and even oligosaccharides suggests both endo-beta-glucuronidase and endo-N-acetylhexosaminidase activities toward both glycosaminoglycans. Cultured skin fibroblasts from mucopolysaccharidosis I patients accumulate the same dermatan sulfate-and heparan sulfate-derived di- and trisaccharides as identified in urine, and supplementation of culture medium with recombinant alpha-l-iduronidase reduced their level to that of unaffected control fibroblasts. A dermatan-derived tetrasaccharide not elevated in mucopolysaccharidosis I fibroblasts transiently increased in these fibroblasts in the presence of recombinant alpha-l-iduronidase, indicating it is an intermediate product of catabolism. These oligosaccharides were elevated in urine samples from mucopolysaccharidosis I patients, and we suggest that these glycosaminoglycan-derived oligosaccharides may be useful biochemical markers for the identification and the clinical management of mucopolysaccharidosis I patients.
authors.affiliation: Lysosomal Diseases Research Unit, Department of Genetic Medicine, Women's and Children's Hospital, 72 King William Road, North Adelaide, South Australia. maria.fuller@adelaide.edu.au
authors.forename: Maria
authors.initials: M
authors.lastname: Fuller
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Meikle
authors.forename: John J
authors.initials: JJ
authors.lastname: Hopwood
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D006224:Cricetinae; D003871:Dermatan Sulfate / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism; D005966:Glucuronidase / Q000378:metabolism; D006025:Glycosaminoglycans / Q000378:metabolism* / Q000652:urine; D006497:Heparan Sulfate / Q000378:metabolism; D006801:Humans; D007067:Iduronic Acid / Q000378:metabolism*; D007068:Iduronidase / Q000378:metabolism*; D008059:Mucopolysaccharidosis I / Q000378:metabolism*; D012867:Skin / Q000378:metabolism; D021241:Spectrometry, Mass, Electrospray Ionization
chemical_list: D003871:Dermatan Sulfate; D005966:Glucuronidase; D006025:Glycosaminoglycans; D006497:Heparan Sulfate; D007067:Iduronic Acid; D007068:Iduronidase